Skip to main content
. 2021 Sep 22;6(12):3035–3044. doi: 10.1016/j.ekir.2021.09.007

Table 1.

Characteristics of the included autopsied diabetic cases at the last health examination within 6 years before death according to the urinary albumin-creatinine ratio levels

Variables Urinary albumin-creatinine ratio, mg/g
P for trend
<30.0
30.0–299.9
≥300.0
n = 41 n = 45 n = 20
Age at the last health examination, yr 75 (9) 77 (9) 78 (10) 0.17
Age at death, yr 78 (9) 80 (9) 81 (10) 0.19
Duration from the last health examination to death, yr 3.2 (1.4) 3.4 (1.6) 2.9 (1.6) 0.68
Male, % 41.5 35.6 65.0 0.17
Hemoglobin A1c, % 6.5 (1.1) 6.7 (1.7) 6.9 (1.2) 0.28
Duration of diabetes mellitus ≥5 yr, % 63.4 71.1 90.0 0.04
Use of diabetic medication, % 68.3 55.6 65.0 0.60
Use of oral hypoglycemic agent, % 56.1 51.1 50.0 0.61
Use of insulin, % 17.1 4.4 25.0 0.76
Systolic blood pressure, mm Hg 133 (16) 142 (22) 150 (20) <0.001
Diastolic blood pressure, mm Hg 76 (11) 78 (10) 80 (13) 0.19
Hypertension, % 70.7 84.4 80.0 0.27
Use of hypertensive medication, % 56.1 64.0 70.0 0.24
Use of ARB/ACE-I, % 39.0 44.4 55.0 0.25
Serum total cholesterol, mmol/l 4.97 (0.93) 4.71 (0.98) 4.71 (1.09) 0.28
Hypercholesterolemia, % 39.0 33.3 65.0 0.12
Use of lipid-modifying medication, % 26.9 24.4 45.0 0.23
Body mass index, kg/m2 23.0 (4.0) 23.6 (3.3) 23.5 (4.1) 0.57
eGFR, ml/min per 1.73 m2 65.6 (13.9) 60.7 (16.0) 54.0 (17.4) 0.007
Current and former smoker, % 51.2 60.0 50.0 0.90
 Current smoker, % 9.8 15.6 10.0
 Former smoker, % 41.5 44.4 40.0

ACE-I, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; eGFR, estimated glomerular filtration rate.

Data are illustrated as the mean values (SD) or percentages.